Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,569
Closed -$6.34K 688
2025
Q1
$6.34K Buy
2,569
+462
+22% +$1.1K ﹤0.01% 608
2024
Q4
$6.62K Buy
+2,107
New +$10.2K ﹤0.01% 596

Other funds holding SLRN

GF Fund Management's SLRN Position: Q2 2025 in Review

GF Fund Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 2,569 shares — an estimated $6.34K sold.

GF Fund Management first reported a position in SLRN in Q4 2024 and held it in 2 quarters. The position peaked at $6.62K in Q4 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • GF Fund Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • GF Fund Management sold 2,569 ACELYRIN shares in Q2 2025, an estimated $6.34K.
  • GF Fund Management first reported a position in ACELYRIN in Q4 2024 and held it in 2 quarters.
  • GF Fund Management's ACELYRIN position peaked at $6.62K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.